Argenx
ARGX
#630
Rank
HK$251.37 B
Marketcap
HK$4,147
Share price
0.56%
Change (1 day)
1.36%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Cash on Hand

Cash on Hand as of June 2024 : HK$24.18 B

According to Argenx 's latest financial reports the company has HK$24.18 B in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Argenx - Cash on Hand chart (from 2021 to 2020)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31HK$17.13 B-5.98%
2021-12-31HK$18.22 B-3.71%
2020-12-31HK$18.92 B44.18%
2019-12-31HK$13.12 B126.54%
2018-12-31HK$5.79 B43.18%
2017-12-31HK$4.04 B387.63%
2016-12-31HK$0.82 B111.92%
2015-12-31HK$0.39 B-39.09%
2014-12-31HK$0.64 B87.14%
2013-12-31HK$0.34 B53.84%
2012-12-31HK$0.22 B-27.46%
2011-12-31HK$0.30 B183.91%
2010-12-31HK$0.10 B